Sky View Investment Advisors, LLC Eli Lilly & CO Transaction History

Sky View Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$434.7 - $599.3 $206,482 - $284,667	-475 Reduced 92.59%	38 $20,000
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $173,265 - $231,676	494 Added 2600.0%	513 $241,000
Q1 2023 May 18, 2023	BUY	$310.63 - $364.82 $5,901 - $6,931	19 New	19 $7,000
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $176,486 - $219,328	-752 Closed	0 $0
Q4 2021 Feb 18, 2022	BUY	$224.85 - $279.04 $169,087 - $209,838	752 New	752 $208,000

4,031

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.